Last 12 months
Inside the activity.
9 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 1 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 5 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 2 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 05, 2025 Filed Mar 6, 2025 22:13 UTC |
O'Byrne KevinDirector
|
PurchaseCommon Stock | 6,500 | $80.44 | $522,832.70 |
DisclosureSEC source: 0001225208-25-003090 · doc4.xml · nonDerivative · entry 1 O'Byrne Kevin · CIK 0001969000 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 6,500 F1 · price: Weighted average price. These shares were purchased in multiple transactions at prices ranging from $80.32 to $80.535 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 21:08 UTC |
Fyrwald J ErikDirector · CEO
|
PurchaseCommon Stock | 25,000 | $80.24 | $2,005,877.50 |
DisclosureSEC source: 0001225208-25-002988 · doc4.xml · nonDerivative · entry 1 Fyrwald J Erik · CIK 0001343564 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,300 F1 · price: Weighted average price. These shares were purchased in multiple transactions at prices ranging from $80.00 to $80.35 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| March 04, 2025 Filed Mar 7, 2025 00:49 UTC |
Borg DeborahEVP, Chief Ppl&Culture Officer
|
Tax withholdingCommon Stock | 123 | $79.79 | $9,814.17 |
DisclosureSEC source: 0001225208-25-003137 · doc4.xml · nonDerivative · entry 2 Borg Deborah · CIK 0001663373 · EVP, Chief Ppl&Culture Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,379 F2 · shares: Shares withheld to satisfy tax withholding obligations in connection with the receipt of shares under the LTIP. Read SEC document |
| March 04, 2025 Filed Mar 7, 2025 00:49 UTC |
Borg DeborahEVP, Chief Ppl&Culture Officer
|
GrantCommon Stock | 269 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-003137 · doc4.xml · nonDerivative · entry 1 Borg Deborah · CIK 0001663373 · EVP, Chief Ppl&Culture Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,502 F1 · shares: These shares represent the 50% portion of the reporting person's payout under the 2022-2024 Long Term Incentive Plan ("LTIP") cycle settled in shares of the issuer's common stock. The number of shares was determined based on the average closing market price of the issuer's common stock for the twenty trading days prior to August 29, 2022, the first stock trading day of the LTIP cycle. Read SEC document |
| March 04, 2025 Filed Mar 7, 2025 00:43 UTC |
Teles de Mendonca Ana PaulaPresident, Scent
|
Tax withholdingCommon Stock | 15 | $79.79 | $1,196.85 |
DisclosureSEC source: 0001225208-25-003126 · doc4.xml · nonDerivative · entry 2 Teles de Mendonca Ana Paula · CIK 0002018707 · President, Scent 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 936 F2 · shares: Shares withheld to satisfy tax withholding obligations in connection with the receipt of shares under the LTIP. Read SEC document |
| March 04, 2025 Filed Mar 7, 2025 00:43 UTC |
Teles de Mendonca Ana PaulaPresident, Scent
|
GrantCommon Stock | 35 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-003126 · doc4.xml · nonDerivative · entry 1 Teles de Mendonca Ana Paula · CIK 0002018707 · President, Scent 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 951 F1 · shares: These shares represent the 50% portion of the reporting person's payout under the 2022-2024 Long Term Incentive Plan ("LTIP") cycle settled in shares of the issuer's common stock. The number of shares was determined based on the average closing market price of the issuer's common stock for the twenty trading days prior to January 1, 2022, the first stock trading day of the LTIP cycle. Read SEC document |
| March 04, 2025 Filed Mar 7, 2025 00:43 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Tax withholdingCommon Stock | 34 | $79.79 | $2,712.86 |
DisclosureSEC source: 0001225208-25-003125 · doc4.xml · nonDerivative · entry 2 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,601 F2 · shares: Shares withheld to satisfy tax withholding obligations in connection with the receipt of shares under the LTIP. Read SEC document |
| March 04, 2025 Filed Mar 7, 2025 00:43 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
GrantCommon Stock | 96 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-003125 · doc4.xml · nonDerivative · entry 1 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,635 F1 · shares: These shares represent the 50% portion of the reporting person's payout under the 2022-2024 Long Term Incentive Plan ("LTIP") cycle settled in shares of the issuer's common stock. The number of shares was determined based on the average closing market price of the issuer's common stock for the twenty trading days prior to January 1, 2022, the first stock trading day of the LTIP cycle. Read SEC document |
| March 04, 2025 Filed Mar 7, 2025 00:42 UTC |
Herriott SimonPres. Health & Bioscience
|
Tax withholdingCommon Stock | 86 | $79.79 | $6,861.94 |
DisclosureSEC source: 0001225208-25-003123 · doc4.xml · nonDerivative · entry 2 Herriott Simon · CIK 0001843592 · Pres. Health & Bioscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,755.324 F2 · shares: Shares withheld to satisfy tax withholding obligations in connection with the receipt of shares under the LTIP. F3 · balance_after: Includes shares acquired during the period pursuant to a dividend reinvestment plan. The transactions were exempt pursuant to Rule 16a-11. Read SEC document |
| March 04, 2025 Filed Mar 7, 2025 00:42 UTC |
Herriott SimonPres. Health & Bioscience
|
GrantCommon Stock | 237 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-003123 · doc4.xml · nonDerivative · entry 1 Herriott Simon · CIK 0001843592 · Pres. Health & Bioscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,841.324 F1 · shares: These shares represent the 50% portion of the reporting person's payout under the 2022-2024 Long Term Incentive Plan ("LTIP") cycle settled in shares of the issuer's common stock. The number of shares was determined based on the average closing market price of the issuer's common stock for the twenty trading days prior to January 1, 2022, the first stock trading day of the LTIP cycle. Read SEC document |
| March 04, 2025 Filed Mar 7, 2025 00:42 UTC |
Johnson Jennifer AmyEVP, General Counsel
|
Tax withholdingCommon Stock | 77 | $79.79 | $6,143.83 |
DisclosureSEC source: 0001225208-25-003124 · doc4.xml · nonDerivative · entry 2 Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,280 F2 · shares: Shares withheld to satisfy tax withholding obligations in connection with the receipt of shares under the LTIP. Read SEC document |
| March 04, 2025 Filed Mar 7, 2025 00:42 UTC |
Johnson Jennifer AmyEVP, General Counsel
|
GrantCommon Stock | 186 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-003124 · doc4.xml · nonDerivative · entry 1 Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,357 F1 · shares: These shares represent the 50% portion of the reporting person's payout under the 2022-2024 Long Term Incentive Plan ("LTIP") cycle settled in shares of the issuer's common stock. The number of shares was determined based on the average closing market price of the issuer's common stock for the twenty trading days prior to January 1, 2022, the first stock trading day of the LTIP cycle. Read SEC document |
| March 04, 2025 Filed Mar 7, 2025 00:42 UTC | Tax withholdingCommon Stock | 42 | $79.79 | $3,351.18 |
DisclosureSEC source: 0001225208-25-003120 · doc4.xml · nonDerivative · entry 2 DeVeau Michael · CIK 0002048900 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,210.572 F2 · shares: Shares withheld to satisfy tax withholding obligations in connection with the receipt of shares under the LTIP. Read SEC document |
|
| March 04, 2025 Filed Mar 7, 2025 00:42 UTC | GrantCommon Stock | 101 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-003120 · doc4.xml · nonDerivative · entry 1 DeVeau Michael · CIK 0002048900 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,252.572 F1 · shares: These shares represent the 50% portion of the reporting person's payout under the 2022-2024 Long Term Incentive Plan ("LTIP") cycle settled in shares of the issuer's common stock. The number of shares was determined based on the average closing market price of the issuer's common stock for the twenty trading days prior to January 1, 2022, the first stock trading day of the LTIP cycle. Read SEC document |
|
| February 03, 2025 Filed Feb 5, 2025 21:58 UTC |
Khan MehmoodDirector
|
GrantRestricted Stock Units · Derivative | 604 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-001284 · doc4.xml · derivative · entry 1 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 604 Underlying: Common Stock · 604 shares Expires 2025-05-01 F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:58 UTC |
JAMISON CYNTHIA TDirector
|
GrantRestricted Stock Units · Derivative | 604 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-001283 · doc4.xml · derivative · entry 1 JAMISON CYNTHIA T · CIK 0001189669 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 604 Underlying: Common Stock · 604 shares Expires 2025-05-01 F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:58 UTC |
INTRIERI VINCENT JDirector
|
GrantRestricted Stock Units · Derivative | 604 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-001282 · doc4.xml · derivative · entry 1 INTRIERI VINCENT J · CIK 0001350114 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 604 Underlying: Common Stock · 604 shares Expires 2025-05-01 F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 21:40 UTC |
Yildiz BerilCAO, SVP & Controller
|
Tax withholdingCommon Stock | 1,340 | $84.17 | $112,787.80 |
DisclosureSEC source: 0001225208-25-000710 · doc4.xml · nonDerivative · entry 2 Yildiz Beril · CIK 0001887484 · CAO, SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,571.37 F2 · shares: Reflects shares withheld for taxes. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 21:40 UTC |
Yildiz BerilCAO, SVP & Controller
|
GrantCommon Stock | 3,976.169 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-000710 · doc4.xml · nonDerivative · entry 1 Yildiz Beril · CIK 0001887484 · CAO, SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,911.37 F1 · shares: Reflects issuer's Common Stock received upon deferral of a portion of the reporting person's annual compensation into the issuer's stock fund. Read SEC document |
| January 02, 2025 Filed Jan 13, 2025 21:19 UTC |
Muller Andres RobertoPresident, Food Ingredients
|
GrantRestricted Stock Units · Derivative | 5,476 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-000610 · doc4.xml · derivative · entry 1 Muller Andres Roberto · CIK 0002048596 · President, Food Ingredients 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,476 Underlying: Common Stock · 5,476 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · derivative.exercise_date: RSUs vest in three equal tranches with respect to 1,825 shares of Common Stock on each of January 2, 2026, January 2, 2027 and 1,826 shares of Common Stock on January 2, 2028, subject to continued employment with IFF. F2 · derivative.expiration_date: RSUs vest in three equal tranches with respect to 1,825 shares of Common Stock on each of January 2, 2026, January 2, 2027 and 1,826 shares of Common Stock on January 2, 2028, subject to continued employment with IFF. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 21:05 UTC |
Finzel RalfEVP, Global Operations Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 5,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-010440 · doc4.xml · derivative · entry 3 Finzel Ralf · CIK 0001952188 · EVP, Global Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,379 Underlying: Common Stock · 5,387 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on December 1, 2022. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs vested on December 1, 2024. F4 · derivative.expiration_date: The RSUs vested on December 1, 2024. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 21:05 UTC |
Finzel RalfEVP, Global Operations Officer
|
Tax withholdingCommon Stock | 1,943 | $91.27 | $177,337.61 |
DisclosureSEC source: 0001225208-24-010440 · doc4.xml · nonDerivative · entry 2 Finzel Ralf · CIK 0001952188 · EVP, Global Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,679 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 21:05 UTC |
Finzel RalfEVP, Global Operations Officer
|
Exercise / conversionCommon Stock | 5,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-010440 · doc4.xml · nonDerivative · entry 1 Finzel Ralf · CIK 0001952188 · EVP, Global Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,622 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on December 1, 2022. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 21:20 UTC |
Arora YuvrajPresident, Nourish
|
SaleCommon Stock | 5,000 | $91.76 | $458,775.00 |
DisclosureSEC source: 0001225208-24-009872 · doc4.xml · nonDerivative · entry 1 Arora Yuvraj · CIK 0001982045 · President, Nourish 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,238 Read SEC document |
| October 03, 2024 Filed Oct 7, 2024 20:34 UTC |
Yildiz BerilCAO, SVP & Controller
|
Exercise / conversionRestricted Stock Units · Derivative | 1,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-009213 · doc4.xml · derivative · entry 3 Yildiz Beril · CIK 0001887484 · CAO, SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,127 Underlying: Common Stock · 1,078 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on October 3, 2022. F4 · derivative.exercise_date: The RSUs vested on October 3, 2024. F4 · derivative.expiration_date: The RSUs vested on October 3, 2024. Read SEC document |
| October 03, 2024 Filed Oct 7, 2024 20:34 UTC |
Yildiz BerilCAO, SVP & Controller
|
Tax withholdingCommon Stock | 389 | $100.63 | $39,145.07 |
DisclosureSEC source: 0001225208-24-009213 · doc4.xml · nonDerivative · entry 2 Yildiz Beril · CIK 0001887484 · CAO, SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,935.201 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| October 03, 2024 Filed Oct 7, 2024 20:34 UTC |
Yildiz BerilCAO, SVP & Controller
|
Exercise / conversionCommon Stock | 1,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-009213 · doc4.xml · nonDerivative · entry 1 Yildiz Beril · CIK 0001887484 · CAO, SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,324.201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on October 3, 2022. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:20 UTC | Exercise / conversionRestricted Stock Units · Derivative | 11,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-009093 · doc4.xml · derivative · entry 3 RICHTER GLENN R · CIK 0001200237 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,392 Underlying: Common Stock · 11,812 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on October 1, 2021. F4 · derivative.exercise_date: The RSUs vested on October 1, 2024. F4 · derivative.expiration_date: The RSUs vested on October 1, 2024. Read SEC document |
|
| October 01, 2024 Filed Oct 3, 2024 20:20 UTC | Tax withholdingCommon Stock | 5,122 | $103.12 | $528,180.64 |
DisclosureSEC source: 0001225208-24-009093 · doc4.xml · nonDerivative · entry 2 RICHTER GLENN R · CIK 0001200237 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,049 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
|
| October 01, 2024 Filed Oct 3, 2024 20:20 UTC | Exercise / conversionCommon Stock | 11,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-009093 · doc4.xml · nonDerivative · entry 1 RICHTER GLENN R · CIK 0001200237 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on October 1, 2021. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
|
| September 03, 2024 Filed Sep 5, 2024 20:05 UTC |
Borg DeborahEVP, Chief HR and D&I Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 11,506 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-008491 · doc4.xml · derivative · entry 6 Borg Deborah · CIK 0001663373 · EVP, Chief HR and D&I Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,090 Underlying: Common Stock · 11,506 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on September 1, 2022 pursuant to the Inducement Award and Buyout Equity Award. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs vested on September 1, 2024. F4 · derivative.expiration_date: The RSUs vested on September 1, 2024. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 20:05 UTC |
Borg DeborahEVP, Chief HR and D&I Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,301 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-008491 · doc4.xml · derivative · entry 5 Borg Deborah · CIK 0001663373 · EVP, Chief HR and D&I Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,596 Underlying: Common Stock · 2,301 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on September 1, 2022 pursuant to the Inducement Award and Buyout Equity Award. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs vested on September 1, 2024. F4 · derivative.expiration_date: The RSUs vested on September 1, 2024. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 20:05 UTC |
Borg DeborahEVP, Chief HR and D&I Officer
|
Tax withholdingCommon Stock | 5,874 | $103.58 | $608,428.92 |
DisclosureSEC source: 0001225208-24-008491 · doc4.xml · nonDerivative · entry 4 Borg Deborah · CIK 0001663373 · EVP, Chief HR and D&I Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,233 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 20:05 UTC |
Borg DeborahEVP, Chief HR and D&I Officer
|
Tax withholdingCommon Stock | 1,175 | $103.58 | $121,706.50 |
DisclosureSEC source: 0001225208-24-008491 · doc4.xml · nonDerivative · entry 3 Borg Deborah · CIK 0001663373 · EVP, Chief HR and D&I Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,107 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 20:05 UTC |
Borg DeborahEVP, Chief HR and D&I Officer
|
Exercise / conversionCommon Stock | 2,301 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-008491 · doc4.xml · nonDerivative · entry 2 Borg Deborah · CIK 0001663373 · EVP, Chief HR and D&I Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,282 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on September 1, 2022 pursuant to the Inducement Award and Buyout Equity Award. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 20:05 UTC |
Borg DeborahEVP, Chief HR and D&I Officer
|
Exercise / conversionCommon Stock | 11,506 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-008491 · doc4.xml · nonDerivative · entry 1 Borg Deborah · CIK 0001663373 · EVP, Chief HR and D&I Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,981 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on September 1, 2022 pursuant to the Inducement Award and Buyout Equity Award. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| July 03, 2024 Filed Jul 5, 2024 20:10 UTC |
Herriott SimonPres. Health & Bioscience
|
Exercise / conversionRestricted Stock Units · Derivative | 627 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-007340 · doc4.xml · derivative · entry 3 Herriott Simon · CIK 0001843592 · Pres. Health & Bioscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,123 Underlying: Common Stock · 627 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on July 3, 2023. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs vested on July 3, 2024. F4 · derivative.expiration_date: The RSUs vested on July 3, 2024. Read SEC document |
| July 03, 2024 Filed Jul 5, 2024 20:10 UTC |
Herriott SimonPres. Health & Bioscience
|
Tax withholdingCommon Stock | 289 | $95.02 | $27,460.78 |
DisclosureSEC source: 0001225208-24-007340 · doc4.xml · nonDerivative · entry 2 Herriott Simon · CIK 0001843592 · Pres. Health & Bioscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,470.257 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| July 03, 2024 Filed Jul 5, 2024 20:10 UTC |
Herriott SimonPres. Health & Bioscience
|
Exercise / conversionCommon Stock | 627 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-007340 · doc4.xml · nonDerivative · entry 1 Herriott Simon · CIK 0001843592 · Pres. Health & Bioscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,759.257 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on July 3, 2023. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:09 UTC |
Palau Hernandez MargaritaDirector
|
GrantRestricted Stock Units · Derivative | 1,543 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-007187 · doc4.xml · derivative · entry 1 Palau Hernandez Margarita · CIK 0001674695 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,543 Underlying: Common Stock · 1,543 shares Expires 2025-05-01 F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. Read SEC document |
| June 13, 2024 Filed Jun 14, 2024 20:56 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Exercise / conversionStock Options (right to buy) · Derivative | 2,588 | $0.00 Strike: $77.16 | $0.00 |
DisclosureSEC source: 0001225208-24-006865 · doc4.xml · derivative · entry 3 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,588 shares Expires 2030-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options vested and became exercisable in three equal tranches with respect to 2,588 shares of Common Stock on each of February 19, 2021, 2022 and 2023. Read SEC document |
| June 13, 2024 Filed Jun 14, 2024 20:56 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
SaleCommon Stock | 2,588 | $95.66 | $247,560.32 |
DisclosureSEC source: 0001225208-24-006865 · doc4.xml · nonDerivative · entry 2 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,539 Read SEC document |
| June 13, 2024 Filed Jun 14, 2024 20:56 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Exercise / conversionCommon Stock | 2,588 | $77.16 | $199,690.08 |
DisclosureSEC source: 0001225208-24-006865 · doc4.xml · nonDerivative · entry 1 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,127 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2024 Filed May 7, 2024 23:06 UTC |
Teles de Mendonca Ana PaulaPresident, Scent
|
Exercise / conversionRestricted Stock Units · Derivative | 726 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005775 · doc4.xml · derivative · entry 6 Teles de Mendonca Ana Paula · CIK 0002018707 · President, Scent 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 726 shares Expires 2024-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F4 · shares: Reflects vesting and settlement of RSUs granted on May 5, 2021. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| May 06, 2024 Filed May 7, 2024 23:06 UTC |
Teles de Mendonca Ana PaulaPresident, Scent
|
Tax withholdingCommon Stock | 262 | $88.66 | $23,228.92 |
DisclosureSEC source: 0001225208-24-005775 · doc4.xml · nonDerivative · entry 4 Teles de Mendonca Ana Paula · CIK 0002018707 · President, Scent 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 916 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| May 06, 2024 Filed May 7, 2024 23:06 UTC |
Teles de Mendonca Ana PaulaPresident, Scent
|
Exercise / conversionCommon Stock | 726 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005775 · doc4.xml · nonDerivative · entry 3 Teles de Mendonca Ana Paula · CIK 0002018707 · President, Scent 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,178 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Reflects vesting and settlement of RSUs granted on May 5, 2021. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| May 03, 2024 Filed May 7, 2024 23:06 UTC |
Yildiz BerilCAO, SVP & Controller
|
Exercise / conversionRestricted Stock Units · Derivative | 848 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005779 · doc4.xml · derivative · entry 3 Yildiz Beril · CIK 0001887484 · CAO, SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,205 Underlying: Common Stock · 848 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on May 3, 2023. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs vested on May 3, 2024. F4 · derivative.expiration_date: The RSUs vested on May 3, 2024. Read SEC document |
| May 03, 2024 Filed May 7, 2024 23:06 UTC |
Yildiz BerilCAO, SVP & Controller
|
Tax withholdingCommon Stock | 342 | $86.64 | $29,630.88 |
DisclosureSEC source: 0001225208-24-005779 · doc4.xml · nonDerivative · entry 2 Yildiz Beril · CIK 0001887484 · CAO, SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,246.201 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| May 03, 2024 Filed May 7, 2024 23:06 UTC |
Yildiz BerilCAO, SVP & Controller
|
Exercise / conversionCommon Stock | 848 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005779 · doc4.xml · nonDerivative · entry 1 Yildiz Beril · CIK 0001887484 · CAO, SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,588.201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on May 3, 2023. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| May 03, 2024 Filed May 7, 2024 23:06 UTC |
O'Byrne KevinDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 1,671 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005776 · doc4.xml · derivative · entry 3 O'Byrne Kevin · CIK 0001969000 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,671 shares Expires 2024-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · price: Upon the vesting of Restricted Stock Units ("RSUs") on May 3, 2024, the reporting person did not defer the receipt of 1,671 shares of Common Stock pursuant to the Company's deferred compensation plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.